NCT02459522

Brief Summary

This study aimed to evaluate the reference values for the short-term heart rate variable (HRV), estimate the performance of cardiovascular autonomic neuropathy (CAN) diagnostic tests in the absence of a gold standard, and assess CAN prevalence in our cross-sectional dataset.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 2, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

September 22, 2016

Status Verified

September 1, 2016

Enrollment Period

5.3 years

First QC Date

May 27, 2015

Last Update Submit

September 20, 2016

Conditions

Keywords

Bayesian estimationshort-term heart rate variabilitycardiovascular autonomic neuropathydiagnostic performance

Outcome Measures

Primary Outcomes (2)

  • Cardiovascular autonomic function evaluate by short-term heart rate variability test

    Both short-term heart rate variability and Ewing's test measure cardiovascular autonomic function

    participants will be measured for the duration of outpatient stay, an expected average of two days

  • Cardiovascular autonomic function evaluate by Ewing's test

    Both short-term heart rate variability and Ewing's test measure cardiovascular autonomic function

    participants will be measured for the duration of outpatient stay, an expected average of two days

Study Arms (1)

Dr.Tang's research group

This group included participants with completed both the short-term HRV test and Ewing's test.

Other: not intervention

Interventions

This is a cross-sectional study for estimation of diagnostic performance.

Dr.Tang's research group

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Individuals with inclusion and exclusion criteria were recruited from healthy examination centres to assess cardiovascular autonomic function using both the short-term heart rate variability and Ewing's tests.

You may qualify if:

  • Survey participants with undiagnosed CAN, aged 30-80 years, were included in this study.

You may not qualify if:

  • history or findings of arrhythmia, and hyperthyroidism or hypothyroidism;
  • pregnancy or lactation; and/or
  • serious hepatic or renal dysfunctions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tongji Hospital

Shanghai, Shanghai Municipality, 200065, China

Location

Related Publications (4)

  • Zeng F, Tang ZH, Li Z, Yu X, Zhou L. Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest. 2014 Apr;37(4):385-91. doi: 10.1007/s40618-013-0047-4. Epub 2014 Jan 9.

  • Tang ZH, Zeng F, Yu X, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard. Int J Cardiol. 2014 Feb 15;171(3):e78-80. doi: 10.1016/j.ijcard.2013.11.100. Epub 2013 Dec 6. No abstract available.

  • Tang ZH, Wang L, Zeng F, Li Z, Yu X, Zhang K, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard. BMJ Open. 2014 Oct 6;4(9):e005096. doi: 10.1136/bmjopen-2014-005096.

  • Tang ZH, Zeng F, Ye K, Yu X, Zhou L. The analysis of a reference value for baroreflex sensitivity and cardiovascular autonomic neuropathy prevalence in a Chinese population. Eur J Med Res. 2014 Feb 12;19(1):8. doi: 10.1186/2047-783X-19-8.

Study Officials

  • Zihui Tang, M.D and Ph.D

    Shanghai Tongji Hospital, Tongji University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D and Ph.D

Study Record Dates

First Submitted

May 27, 2015

First Posted

June 2, 2015

Study Start

January 1, 2011

Primary Completion

May 1, 2016

Study Completion

June 1, 2016

Last Updated

September 22, 2016

Record last verified: 2016-09

Locations